Cure Number 1
Dr. Burzynski, a nationally and internationally recognized physician/investigator, pioneered the use of biologically active peptides for the treatment of cancer. In 1967, at the age of 24, Dr. Burzynski graduated first in his class of 250 students from the Medical Academy in Lublin, Poland. It was at this time that he identified naturally occurring human peptides, which were deficient in cancer patients. He concluded that these peptides played a role in preventing the growth of cancer cells. In 1968, he earned a PhD degree and became one of the youngest physician/investigators in Poland to hold both a MD and PhD degree.
Between 1970 and 1977, he received funding from the National Cancer Institute (NCI) for his work as an investigator and Assistant Professor at the Baylor College of Medicine in Houston, TX. During this time he authored/coauthored 16 publications, including five detailing his work on naturally occurring human peptides and their effect on cancer – four of which were co-authored by investigators associated with the M.D. Anderson Cancer Center or the Baylor College School of Medicine. In May 1977, Dr. Burzynski received a Certificate of Appreciation from the Baylor College of Medicine that acknowledged his contributions to the ‘Advancement of Medical Education, Research, and Health Care’.
In 1977 that the Burzynski Clinic was established in Houston, TX. Since then, more than 8,000 patients have received treatment at the clinic, including more than 2,300 cancer patients who have been treated in FDA reviewed and Institutional Review Board (IRB) approved clinical trials program of Antineoplastons, investigational agents that derived from Dr. Burzynski’s early investigations of naturally occurring human peptides. Currently, new FDA-reviewed Phase II and III clinical studies utilizing Antineoplastons are awaiting Institutional Review Board (IRB) approval prior to patient enrolment.
Dr. Burzynski has extensive experience treating cancer with combinations of targeted agents and the drug phenylbutyrate (PB), which targets multiple genetic abnormalities simultaneously.
Antineoplastons are responsible for curing some of the most incurable forms of terminal cancer. Various cancer survivors are presented in the film who chose these medicines instead of surgery, chemotherapy or radiation – with full disclosure of medical records to support their diagnosis and recovery – as well as systematic (non-anecdotal) FDA-supervised clinical trial data comparing Antineoplastons to other available treatments—which is published within the peer-reviewed medical literature.
One form of cancer – diffuse, intrinsic, childhood brainstem glioma has never before been cured in any scientifically controlled clinical trial in the history of medicine. Antineoplastons hold the first cures in history – dozens of them.
Burzynski: Cancer Is Serious Business (Pt. 1, Trailer 1)
This documentary takes the audience through the treacherous, yet victorious, 14-year journey both Dr. Burzynski and his patients have had to endure in order to obtain FDA-approved clinical trials of Antineoplastons.
Dr. Burzynski was able to initially produce and administer his discovery without FDA-approval from 1977-1995 because the state of Texas at this time did not require that Texas physicians be required to adhere to Federal law in this situation. This law has since been changed.
As with anything that changes current-day paradigms, Burzynski’s ability to successfully treat incurable cancer with such consistency has baffled the industry. Ironically, this fact had prompted numerous investigations by the Texas Medical Board, who relentlessly took Dr. Burzynski as high as the state supreme court in their failed attempt to halt his practices.
Likewise, the Food and Drug Administration engaged in four Federal Grand Juries spanning over a decade attempting to indict Dr. Burzynski, all of which ended in no finding of fault on his behalf. Finally, Dr. Burzynski was indicted in their 5th Grand Jury in 1995, resulting in two federal trials and two sets of jurors finding him not guilty of any wrongdoing. If convicted, Dr. Burzynski would have faced a maximum of 290 years in a federal prison and $18.5 million in fines.
However, what was revealed a few years after Dr. Burzynski won his freedom, helps to paint a more coherent picture regarding the true motivation of the United States government’s relentless persecution of Stanislaw Burzynski, M.D., Ph.D.
The FDA and BigPharma Try to Silence Burzynski in Part II (trailer):
Burzynski: Cancer Is Serious Business, Part II | Trailer #2
Synopsis: In the compelling follow-up to ‘Burzynski, the Movie’, the internationally award-winning documentary, ‘Burzynski: Cancer is Serious Business, Part II’ explores the current status of Antineoplastons’ clinical testing sanctioned by the United States Food & Drug Administration—and features a modern story of the struggling journeys of cancer patients being treated today at the Burzynski Clinic in Houston, Texas.
For most patients undergoing Burzynski’s treatment, their advanced cancer itself runs secondary to the constant barrage of skepticism coming not only from their local oncologists, but also from friends and family who feel their loved ones are making suspect treatment decisions—even though mainstream oncology has already left many dead.
As the story unfolds, the audience will observe a real-time change of hearts and minds from many of these doctors and families. Unlike the first documentary in the series, Part II showcases interviews with board-certified oncologists, surgeons and neurosurgeons, who witnessed patients leave their care, soon to return in great health after opting for the Burzynski Clinic.
Since the mapping of the Cancer Genome, Burzynski has pioneered an expansion of his therapy, which he calls “Personalized Gene-Targeted Cancer Therapy,” where the patient’s Genomic Cancer Atlas is mapped and a treatment regimen is personally tailored for each individual patient, as opposed to the conveyor belt, “one-size-fits-all” approach that current oncology adheres to.
Patients denied access to therapy
Due to the slow-moving, bureaucratic obstacles enforced on Antineoplastons by America’s FDA, this new expanded “personalized gene-targeted” direction has allowed more patients (who are denied access to Antineoplastons) to benefit from Burzynski’s practice in ways never before thought possible. And yet, still with similar resistance and controversy endured by Burzynski’s Antineoplaston therapy.
The film also takes you to Kurume University in Fukuoka, Japan—where independently designed studies of Antineoplastons have been underway for 27 years—without Dr. Burzynski’s (the inventor’s) involvement or supervision. Learn how this team of Japanese pathologists, oncologists and surgeons have studied these anti-cancer compounds using their own methodologies—resulting in the first ever independently-run randomized controlled clinical trials.
“After twenty-seven years of independently testing Antineoplastons—including randomized clinical trials, we found that Dr. Burzynski was right. It’s obviously not anecdotal anymore.”
—Hideaki Tsuda, MD – 2013, Kurume Medical University, Fukuoka Prefecture, Japan
The viewer will experience the turbulent process in which the industry utilizes its now usurped regulatory agency to both block Antineoplastons’ Phase 3 clinical trial process—and orchestrate a group of “information hit-men”.
Astroturf Campaign
Campaigns & Elections magazine defined astroturf as a “grassroots program that involves the instant manufacturing of public support for a point of view in which either uninformed activists are recruited or means of deception are used to recruit them.
You will be placed into the turbulent journey of how the industry utilizes its now usurped regulatory agency to both block Antineoplastons’ Phase 3 clinical trial process—and orchestrate a group of “information hit men” (also known as an “Astroturf Campaign”) to pollute all channels of public information in an effort to confuse the public over the truth behind Antineoplastons. This international Astroturf group also engages in the intimidation and harassment of prospective and current terminal cancer patients under Dr. Burzynski’s care.
However, most notable of all—are the earth-shattering events that occurred upon the final days of production of this film—you’ll be left speechless, yet with so much to say, when you witness the story and shocking conclusion to Burzynski: Cancer Is Serious Business, Part II.
“I can’t imagine a world where other people will not have the privilege that I have had—the privilege to have their life saved by a new technology that can cure cancer—it’s terrifying.”
– Laura Hymas – 2013, Glioblastoma Grade IV brain cancer patient, after experiencing a complete remission under Antineoplaston therapy.
Burzynski: Cancer Cure Cover-Up – Trailer:
(2016) Burzynski: Cancer Cure Cover-Up – Trailer
Synopsis: Burzynski: The Cancer Cure Cover-up is the story of a pioneering medical doctor and PhD biochemist who has discovered a unique and proprietary method of treating most cancers. This documentary takes the audience through the treacherous, yet victorious, near 50-year journey both Dr. Burzynski and his patients have had to endure in order to obtain FDA-approved clinical trials of Antineoplastons. Defying the face of skepticism, legal attacks from state and federal agencies, and a powerful propaganda campaign to stop Burzynski – this doctor and his patients are still going strong.
Cure number 2
Advocates of laetrile, also known as vitamin B17, suggested that it possessed anti-cancer properties and claimed it could be used for cancer prevention and treatment. Some of the specific claims made in the past regarding vitamin B17 and laetrile include:
1. Anti-cancer effects: It was suggested that laetrile could selectively target and destroy cancer cells while leaving healthy cells unharmed.
2. Cancer prevention: Proponents argued that consuming foods rich in amygdalin (such as apricot kernels) or using laetrile supplements could prevent the development of cancer.
3. Boosting the immune system: It was claimed that vitamin B17 could enhance the immune system, leading to improved cancer resistance.
4. Pain relief: Some proponents believed that laetrile had pain-relieving properties and could alleviate cancer-related pain.
Full documentary and article on this cure here: https://teslatelegraph.com/2023/05/31/world-without-cancer-the-story-of-vitamin-b17-by-g-edward-griffin-1974/
Cure number 3
During the Cold War Era of the 1960s, Russian researchers were looking for ways to support the immune system in conditions running the gamut from cancer to bio-warfare agents. Eastern Europeans, with a cultural love of fermented milk products, logically looked to probiotics, or lactobacillus, for immune support because it was safe, cheap and effective.
A Bulgarian researcher and medical doctor, Dr. Ivan Bogdanov, researched lactobacillus bacteria in the 1960s. Bogdanov believed that specific strains of probiotics could have anti-tumor properties.
The doctor’s research team injected mice with a sarcoma cancer, then administered a crude mixture of cell fragments from a strain of Lactobacillus delbrukii. Bogdanov observed that the cancer disappeared within a few days. Subsequently, researchers attempted to re-grow cancer in the same mice, but without success — the mice seemed immune to the cancer cells.
Full article and cure on this including probiotic list is here: https://teslatelegraph.com/2023/05/17/how-probiotics-cured-cancer-and-saved-lives-after-chernobyl/
Cure number 4
Turkey tail mushroom is a common woodland fungus with a distinctive fan-like appearance, resembling the colorful feathers of a wild turkey’s tail. It has been used for centuries in traditional Chinese and Japanese medicine due to its reputed health benefits. However, modern scientific research has shed new light on this humble mushroom’s potential in fighting cancer.
Promising Studies and Findings:
Paul Stamets’ pioneering research has focused on turkey tail mushroom extracts and their impact on cancer treatment. He discovered that turkey tail mushrooms contain bioactive compounds, particularly polysaccharopeptides (PSP) and polysaccharide-K (PSK), which possess powerful anti-cancer properties. These compounds are believed to stimulate the immune system, enhance the body’s natural defense mechanisms, and potentially inhibit the growth of cancer cells.
Full article on this here: https://teslatelegraph.com/2023/06/01/paul-stamets-and-the-fascinating-studies-on-turkey-tail-mushrooms-potential-in-cancer-treatment/
Leave a Reply